Richard D. Truesdell, Jr.
Lawyers
Filters
Cigna $1.5 billion senior notes offering
The senior notes are due 2026 and 2033
Assurant $175 million senior notes offering
We advised Assurant on the senior notes offering
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Biodesix $40 million follow-on offering
The shares are listed on the Nasdaq Global Market
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
Zoetis $1.35 billion senior notes offering
The investment-grade notes are due 2025 and 2032
Kinsale Capital Group follow-on offering
The stock is listed on the NYSE
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE